7th Winner | Dr. Eberhard Grube
Dr. Eberhard Grube, MD, a Professor of Medicine at University Hospital Bonn, Germany and a Consulting Professor of the Division of Medicine at Stanford University School of Medicine, has been selected as the recipient of the 7th TCTAP Award “Master of the Masters” for his achievement to the field of interventional cardiology and the growth of CardioVascular Summit-TCTAP as well. The award ceremony was held on Wednesday, April 26 at the Main Arena.
TCTAP Award “Master of the Masters” is bestowed annually upon the most distinguished cardiologist who has made meritorious contributions and played a significant leading role in the field of interventional cardiology as well as in TCTAP over the years.
Dr. Eberhard Grube was born in Hamburg, Germany in 1944. After graduation from the Rhenish Friedrich-Wilhelm University in Bonn, Germany, he started his career as a physician at University hospital Bonn from 1979 until now. Over the past decade, Dr. Grube has taken lead in the initial clinical testing of drug-eluting stents, percutaneous closure devices, new atherectomy techniques, catheterbased valve surgery, and treatment of vulnerable plaque. He has been well-known as an early investigator in the field of TAVR. His study for improving the performance of TAVR devices and developing new treatment for valvular heart disease laid the groundwork for future development.
In recognition of his outstanding achievement, he received a Geoffrey Hartzler Master Clinical Operator Award in the annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium sponsored by the Cardiovascular Research Foundation (CRF) in 2009.
Dr. Martin Bert Leon, who is his friend and the 2nd recipient of TCTAP Award “Master of the Masters”, said, “He is truly an unique individual with an intuitive understanding of how devices work, how they can be applied for specific new clinical applications and has both the technical skills and the cognitive understanding to be able to make the connection so that we can begin the complex process of innovative new devices development”.
As a wise teacher and leader, his effort to contribute to the medical advance and the growth of next generation in interventional cardiology continues even now.
